Cystic Fibrosis Ppt

Embed Size (px)

Citation preview

  • 8/3/2019 Cystic Fibrosis Ppt

    1/32

    MANISHA PADMAKUMAR

    11408025

  • 8/3/2019 Cystic Fibrosis Ppt

    2/32

    INTRODUCTION

    Cystic fibrosis is a genetic disorder that mainly

    affects the digestive systems and lungs.

    The exocrine glands like those secreting sweat,

    mucus, digestive fluids, etc are mainly affected.

    Abnormally thick mucus and salty sweat isproduced which are the main cause of other

    symptoms in cystic fibrosis.

    It might cause early death due to multiple organ

    failure.

    It is most common in caucasian populations.

  • 8/3/2019 Cystic Fibrosis Ppt

    3/32

    HISTORYIt was misdiagnosed as whooping cough,pneumonia,bronchitis,etc.

    But awareness traced back to 1700s.

    Discovered and studied 1930 onwards.

    The term cystic fibrosis was coined by Dr. Dorothy Andersen who

    published an article, "Cystic Fibrosis of the Pancreas and Its Relation to

    Celiac Disease: a Clinical and Pathological Study," in 1938

    and hypothesized that CF was a recessive disease .

    1952 Paul di Sant Agnese discovered abnormalities in sweat-thus sweat

    test.1988 the first mutation for CF, F508 was discovered by Francis

    Collins, Lap-Chee Tsui and John R. Riordan.

  • 8/3/2019 Cystic Fibrosis Ppt

    4/32

    PREVALENCE

    In the world

    In the United States, approximately 30,000 individuals, 3000 Canadians,

    and 20,000 Europeans have CF.

    Occurs mostly in whites of caucasian decent.

    Less common in African Americans, Native Americans, and Asian

    Americans.

    2500 babies are born with CF each year in the United States

    1 in every 20 Americans is an unaffected carrier of an abnormal CF gene.

    In India

    No statistics are found as it might be misdiagnosed.

    But according to the statistics of indians settled in US and UK, the

    incidence should be possibly 100,000 patients in India.

  • 8/3/2019 Cystic Fibrosis Ppt

    5/32

    CELEBRITIES WITH CYSTIC

    FIBROSIS

    Lisa Bentley (Canadian

    Ironman triathlete)

    Bob Flannagan(American

    performance artist, comic, writer,poet, and musician.)

  • 8/3/2019 Cystic Fibrosis Ppt

    6/32

    SYMPTOMS

    GENERAL SYMPTOMSsalty tasting skin

    poor growth and poor weight gain despite a normal food

    intake

    accumulation of thick, sticky mucusfrequent chest infections

    coughing or shortness of breath

    Males can be infertile sometimes

    Digestive problems frequent affected newborn infant fails to pass faeces (meconium)

    protrusion of internal rectal membranes (rectal prolapse)

    Clubbed fingers and toes

  • 8/3/2019 Cystic Fibrosis Ppt

    7/32

    HOW CYSTIC FIBROSIS

    AFFECTS THE BODYSWEAT GLANDS-

    Sweat produced too salty(2-5 times more

    than normal)

    Thus more exhaustion or more sweating

    leads to salt loss and dehydration

  • 8/3/2019 Cystic Fibrosis Ppt

    8/32

    RESPIRATORY SYSTEM-Normally epithelial cells lining the respiratory tracts and

    the exocrine glands in the airways produce a thin slipperysecretion called MUCUS.

    It provides a protective lubricant coating which captures

    microbes and dust from getting into the lungs and causinginfections. This can be coughed out by the body with the

    help of cilia.

    In CF mucus produced is thick and sticky. This inhibits

    movement of cilia and thus plugs the airways and ducts

    and accumulates microbes. Causes infections.

  • 8/3/2019 Cystic Fibrosis Ppt

    9/32

  • 8/3/2019 Cystic Fibrosis Ppt

    10/32

    Infections lead to inflammation which causes

    airways to get blocked and thus breathing problems

    result.This cycle continues,spreading the infection and

    thus damaging the the lungs(pulmonary

    exacerbation.

    Thus coughing, wheezing, pneumonia, bronchitis.

  • 8/3/2019 Cystic Fibrosis Ppt

    11/32

  • 8/3/2019 Cystic Fibrosis Ppt

    12/32

  • 8/3/2019 Cystic Fibrosis Ppt

    13/32

    Malnutrition and weak. Rectal prolapse.

    Can also lead to pancreatic or intestinal inflammation.

    If pancreas impaired,islet cells affected. Thus diabetes

    can also occur.

    Vitamin absortion decreases causing severe weakness.

  • 8/3/2019 Cystic Fibrosis Ppt

    14/32

    REPRODUCTORY SYSTEMIn men with CF sometimes vas deference in blocked or

    absent. Sperm production and transport affected.

    Thus almost 97% of men with CF are infertile(not

    sterile).

    In women also conceiving might become a problem

    due to blockage of reproductory tracts by mucus but

    mostly they are not infertile.

  • 8/3/2019 Cystic Fibrosis Ppt

    15/32

    GENETIC AND MOLECULAR BASIS OF

    CYSTIC FIBROSIS

    Locus: 7q31.2

    Gene Structure: The normal allelic variant

    for this gene is about 250,000 bp long and

    contains 27 exons.

    Coding Sequence (CDS): 4443 bp within

    the mRNA code for the amino acid sequence

    of the gene's protein product.

    Protein Size: The CFTR protein is 1480

    amino acids long and has a molecular weight

    of 168,173 Da.

  • 8/3/2019 Cystic Fibrosis Ppt

    16/32

    THE CFTR PROTEIN-It is the cystic fibrosis transmembrane conductance regulator protein.

    The normal CFTR protein product is a chloride channel protein found in

    membranes of cells that line passageways of the lungs, liver, pancreas, intestines,reproductive tract, and skin. CFTR is also involved in the regulation of other

    transport pathways.

    It generally has five domains: two membrane-spanning domains (MSD1 and

    MSD2) that form the chloride ion channel, two nucleotide-binding domains (NBD1

    and NBD2) that bind and hydrolyze ATP (adenosine triphosphate), and a

    regulatory (R) domain.

  • 8/3/2019 Cystic Fibrosis Ppt

    17/32

    NORMAL FUNCTION OF CFTR-Regulates movement of chloride ions out of mucus

    producing cells.Thus water follows by osmosis principle.

    So mucus thinned and slippery.

    CFTR functions principally as a cAMP-induced

    IN CASE OF CF-Mutated CFTR cannot allow chloride ions to move out of

    the cells.

    Water cannot escape and thin the mucus.Thus mucus is thick and forms clogs.

  • 8/3/2019 Cystic Fibrosis Ppt

    18/32

  • 8/3/2019 Cystic Fibrosis Ppt

    19/32

    MUTATIONDelta F508, the most common CF-causing mutation, occurs in

    the DNA sequence that codes for the first nucleotide-binding

    domain (NBD1).

    508 is a deletion() of 3 nucleotides that result in the loss of

    the amino acid at the phenylalanine position at the 508th position

    of the protein.

    3-D STRUCTURE OF NBD1 DOMAIN

  • 8/3/2019 Cystic Fibrosis Ppt

    20/32

    CONTINUED.

    When a CFTR protein with the delta F508 mutation reaches the

    ER, the quality-control mechanism of this cellular componentrecognizes that the protein is folded incorrectly and marks the

    defective protein for degradation. As a result, delta F508 never

    reaches the cell membrane.

    People who are homozygous for delta F508 mutation tend to have

    the most severe symptoms of cystic fibrosis due to critical loss of

    chloride ion transport.

    This mutation accounts for two-thirds (66-70%) worldwide and90% of cases in United States,however there are 1400 other

    mutations that can produce CF.

  • 8/3/2019 Cystic Fibrosis Ppt

    21/32

    INHERITANCE PATTERNCystic fibrosis has anautosomal recessive inheritance

    Thus if both the parents are carriers, the child has 25% chances of

    becoming affected and 50% chances of being a carrier.Since autosomal, can occur in male and female populations alike.

  • 8/3/2019 Cystic Fibrosis Ppt

    22/32

    DIAGNOSIS

    SWEAT TESTSweat glands are activated by a chemical called pilocarpine

    and mild electricity.

    Gauze pad or filter paper used to collect the accumulated

    sweat.Normal sweat chloride content 60 is diagnostic for CF(for

    infants over 6 months.

  • 8/3/2019 Cystic Fibrosis Ppt

    23/32

    GENETIC TESTINGBlood or buccal smear tested for F508 mutation

    70% are homozygous for F508 mutation. Others have one

    F508 mutation and another form of CFTRmutation(heterozygous)

    NEW BORN SCREENINGIMMUNOREACTIVE TRYPSINOGEN test is done in 2-3 days

    of the birth of the baby from blood sample.

    If levels high, CF positive.

    CARRIER SCREENING

    Before pregnancy,blood test performed on healthy adultswith family history of CF to determine whether they carry a

    recessive gene mutation that could cause disease in their

    children.

  • 8/3/2019 Cystic Fibrosis Ppt

    24/32

    PRENATAL TESTINGAMNIOCENTESIS-

    Done in the second trimester ,typically between the 15th and 18th

    weeks of pregnancy.thin needle is inserted into the uterus through the abdomen and a

    small amount of amniotic fluid is drawn out which is then analyzed

    for genetic and chromosomal abnormalities.

    CHORIONIC VILLI SAMPLING-

    Done in the first trimester, between the 10th and 12th week of

    pregnancy.

    thin needle inserted into the uterus through either the abdomen or

    the cervix

    Small sample of placenta is removed and analyzed for any genetic

    and chromosomal abnormalities.

  • 8/3/2019 Cystic Fibrosis Ppt

    25/32

    MOLECULAR DIAGNOSIS

    Multiplex ligation dependent probe amplification(MLPA)

    Quantitative fluorescent multiplex PCR

  • 8/3/2019 Cystic Fibrosis Ppt

    26/32

    TREATMENT

    LUNG DISORDERSChest Physical Therapy

    CPT also is called chest clapping or percussion. It involves pounding

    the chest and back over and over with hands or electrical percussor

    to loosen the mucus from lungs so that it can be coughed up.

    Exercise

    Not too much as salt content is lost due to sweating.

    Medicines

    Antibiotics are the main treatment to prevent or treat lung

    infections. They can be oral, inhaled, or intravenous (IV) antibiotics.Inhaled medicines generally given by aerosols or metered dose

    inhalers.(MDI)

    Nebulizers can also be used.

  • 8/3/2019 Cystic Fibrosis Ppt

    27/32

    Medicines ctnd.BRONCHODIALATORS-open airways,clear mucus. Eg-Albuterol

    MUCOLYTICS-Thins mucus. Eg-Pulmozyme

    ANTI-INFLAMMATORY- Reduces inflammations. Eg-steroids and non-steroidal Ibuprofen

    ANTIBIOTICS-Fights infection. Eg-Tobramycin

    Oxygen therapyLung transplants

  • 8/3/2019 Cystic Fibrosis Ppt

    28/32

    DIGESTIVE DISORDERSNutritional therapy-

    a well-balanced diet that's rich in calories, fat, and proteinOral pancreatic enzymes to help digest fats,proteins and

    absorb more vitamins.

    Supplements of vitamins A, D, E, and K

    High-calorie shakes

    A high-salt diet or salt supplements

    Oral pancreatic enzymes

    Antacids

    Surgery- of blocked intestines or pancreas.

  • 8/3/2019 Cystic Fibrosis Ppt

    29/32

    GENE THERAPYUse of normal DNA to correct for the damaged genes

    that cause diseaseIn the case of CF, gene therapy involves inhaling a spray

    that delivers normal DNA to the lungs

    The goal is to replace the defective CF gene in the lungs

    to cure or slow the progression of the diseaseMore research is going on in this area to improve

    methods for transfer of therapeutic DNA into the affected

    patient with minimum or no risks

  • 8/3/2019 Cystic Fibrosis Ppt

    30/32

    PREVENTION

    Through carrier screening if both parents arefound to be carriers, the couple should go for

    genetic counseling before having a baby.

    IVF techniques can be used to select healthy

    embryo for carrier parents.

    Awareness about the disease in general

  • 8/3/2019 Cystic Fibrosis Ppt

    31/32

    REFERENCES

    Wikipedia

    www.cff.org

    www.medecinenet.com

    Ghr.nlm.nih.gov

    www.ornl.gov

    www.news-medical.net

    www.genome.gov

    http://www.cff.org/http://www.medecinenet.com/http://www.ornl.gov/http://www.news-medical.net/http://www.genome.gov/http://www.genome.gov/http://www.news-medical.net/http://www.news-medical.net/http://www.news-medical.net/http://www.ornl.gov/http://www.medecinenet.com/http://www.cff.org/
  • 8/3/2019 Cystic Fibrosis Ppt

    32/32

    THANKYOU